·Confidence 85%
AstraZeneca's Breast Cancer Drug Trial Failure Could Impact Sales
AstraZeneca's recent breast cancer pill trial failure may lead to a loss of several billion dollars in potential sales, analysts warn.
1 article tagged with #Breast Cancer
AstraZeneca's recent breast cancer pill trial failure may lead to a loss of several billion dollars in potential sales, analysts warn.